Top

Journal of Assisted Reproduction and Genetics

Published in:

01-03-2014 | Gamete Biology

Effects of differing oocyte-secreted factors during mouse in vitro maturation on subsequent embryo and fetal development

Authors: J. Sudiman, L. J. Ritter, D. K. Feil, X. Wang, K. Chan, D. G. Mottershead, D. M. Robertson, J. G. Thompson, R. B. Gilchrist

Published in: Journal of Assisted Reproduction and Genetics | Issue 3/2014

Abstract

Purpose

We hypothesised that varying native oocyte-secreted factor (OSF) exposure or using different recombinant OSF peptides would have differential effects on post-in vitro maturation (IVM) embryo and fetal development.

Methods

Mouse cumulus oocyte complexes (COCs) were treated with the purified mature domain of GDF9 and/or BMP15 or were co-cultured with denuded oocytes (DOs) from 0 h or 3 h of IVM. DOs were matured for 3 h as either intact COCs+/-FSH before denuding, or as DOs + FSH. COCs were fertilised and blastocyst development was assessed on days 5 and 6, and either differentially stained for ICM numbers or vitrified/warmed embryos were transferred to recipients to assess implantation and fetal rates.

Results

No improvement in embryo development was observed with the addition of GDF9 and/or BMP15 to IVM. In contrast, embryos derived from COCs co-cultured with DOs had significantly improved blastocyst rates and ICM numbers compared to controls (P < 0.05). The highest response was obtained when DOs were first added to COCs at 3 h of IVM, after being pre-treated (0–3 h) as COCs + FSH. Compared to control, co-culture with DOs from 3 h did not affect implantation rates but more than doubled fetal yield (21 % vs 48 %; P < 0.05). GDF9 Western blot analysis was unable to detect any differences in quantity or form of GDF9 (17 and 65 kDa) in extracts of DO at 0 h or 3 h.

Conclusions

This study provides new knowledge on means to improve oocyte quality in vitro which has the potential to significantly aid human infertility treatment and animal embryo production technologies.

Gremeau AS, Andreadis N, Fatum M, Craig J, Turner K, McVeigh E, et al. In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles. Fertil Steril. 2012;98:355–60.PubMedCrossRef

Gilchrist RB. Recent insights into oocyte-follicle cell interactions provide opportunities for the development of new approaches to in vitro maturation. Reprod Fertil Dev. 2011;23:23–31.PubMedCrossRef

Gilchrist RB, Ritter LJ, Armstrong DT. Oocyte-somatic cell interactions during follicle development in mammals. Anim Reprod Sci. 2004;82–83:431–46.PubMedCrossRef

Gilchrist RB, Ritter LJ, Myllymaa S, Kaivo-Oja N, Dragovic RA, Hickey TE, et al. Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation. J Cell Sci. 2006;119:3811–21.PubMedCrossRef

Vanderhyden BC, Telfer EE, Eppig JJ. Mouse oocytes promote proliferation of granulosa cells from preantral and antral follicles in vitro. Biol Reprod. 1992;46:1196–204.PubMedCrossRef

Hussein TS, Froiland DA, Amato F, Thompson JG, Gilchrist RB. Oocytes prevent cumulus cell apoptosis by maintaining a morphogenic paracrine gradient of bone morphogenetic proteins. J Cell Sci. 2005;118:5257–68.PubMedCrossRef

Li R, Norman RJ, Armstrong DT, Gilchrist RB. Oocyte-secreted factor(s) determine functional differences between bovine mural granulosa cells and cumulus cells. Biol Reprod. 2000;63:839–45.PubMedCrossRef

Salustri A, Yanagishita M, Hascall VC. Mouse oocytes regulate hyaluronic acid synthesis and mucification by FSH-stimulated cumulus cells. Dev Biol. 1990;138:26–32.PubMedCrossRef

Caixeta E, Sutton-McDowall M, Gilchrist RB, Thompson JG, Price C, Machado MF, et al. Bone morphogenetic protein 15 and fibroblast growth factor 10 enhance cumulus expansion, glucose uptake and expression of genes in the ovulatory cascade during in vitro maturation of bovine cumulus-oocyte complexes. Reproduction. 2013.

10.

Su YQ, Sugiura K, Wigglesworth K, O’Brien MJ, Affourtit JP, Pangas SA, et al. Oocyte regulation of metabolic cooperativity between mouse cumulus cells and oocytes: BMP15 and GDF9 control cholesterol biosynthesis in cumulus cells. Development. 2008;135:111–21.PubMedCrossRef

11.

Sugiura K, Su YQ, Diaz FJ, Pangas SA, Sharma S, Wigglesworth K, et al. Oocyte-derived BMP15 and FGFs cooperate to promote glycolysis in cumulus cells. Development. 2007;134:2593–603.PubMedCrossRef

12.

Sutton-McDowall ML, Mottershead DG, Gardner DK, Gilchrist RB, Thompson JG. Metabolic differences in bovine cumulus-oocyte complexes matured in vitro in the presence or absence of follicle-stimulating hormone and bone morphogenetic protein 15. Biol Reprod. 2012;87:87.PubMedCrossRef

13.

Dragovic RA, Ritter LJ, Schulz SJ, Amato F, Armstrong DT, Gilchrist RB. Role of oocyte-secreted growth differentiation factor 9 in the regulation of mouse cumulus expansion. Endocrinology. 2005;146:2798–806.PubMedCrossRef

14.

Dragovic RA, Ritter LJ, Schulz SJ, Amato F, Thompson JG, Armstrong DT, et al. Oocyte-secreted factor activation of SMAD 2/3 signaling enables initiation of mouse cumulus cell expansion. Biol Reprod. 2007;76:848–57.PubMedCrossRef

15.

Eppig JJ, Downs SM. Chemical signals that regulate mammalian oocyte maturation. Biol Reprod. 1984;30:1–11.PubMedCrossRef

16.

Salustri A, Siracusa G. Metabolic coupling, cumulus expansion and meiotic resumption in mouse cumuli oophori cultured in vitro in the presence of FSH or dcAMP, or stimulated in vivo by hCG. J Reprod Fertil. 1983;68:335–41.PubMedCrossRef

17.

Salustri A, Yanagishita M, Hascall VC. Synthesis and accumulation of hyaluronic acid and proteoglycans in the mouse cumulus cell-oocyte complex during follicle-stimulating hormone-induced mucification. J Biol Chem. 1989;264:13840–7.PubMed

18.

Thomas RE, Armstrong DT, Gilchrist RB. Bovine cumulus cell-oocyte gap junctional communication during in vitro maturation in response to manipulation of cell-specific cyclic adenosine 3′,5′-monophosophate levels. Biol Reprod. 2004;70:548–56.PubMedCrossRef

19.

Gilchrist RB, Lane M, Thompson JG. Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum Reprod Update. 2008;14:159–77.PubMedCrossRef

20.

Dey SR, Deb GK, Ha AN, Lee JI, Bang JI, Lee KL, et al. Coculturing denuded oocytes during the in vitro maturation of bovine cumulus oocyte complexes exerts a synergistic effect on embryo development. Theriogenology. 2012;77:1064–77.PubMedCrossRef

21.

Wongsrikeao P, Kaneshige Y, Ooki R, Taniguchi M, Agung B, Nii M, et al. Effect of the removal of cumulus cells on the nuclear maturation, fertilization and development of porcine oocytes. Reprod Domest Anim. 2005;40:166–70.PubMedCrossRef

22.

Zhang L, Jiang S, Wozniak PJ, Yang X, Godke RA. Cumulus cell function during bovine oocyte maturation, fertilization, and embryo development in vitro. Mol Reprod Dev. 1995;40:338–44.PubMedCrossRef

23.

Ali A, Sirard MA. Protein kinases influence bovine oocyte competence during short-term treatment with recombinant human follicle stimulating hormone. Reproduction. 2005;130:303–10.PubMedCrossRef

24.

Merriman JA, Whittingham DG, Carroll J. The effect of follicle stimulating hormone and epidermal growth factor on the developmental capacity of in-vitro matured mouse oocytes. Hum Reprod. 1998;13:690–5.PubMedCrossRef

25.

Crawford JL, McNatty KP. The ratio of growth differentiation factor 9: bone morphogenetic protein 15 mRNA expression is tightly co-regulated and differs between species over a wide range of ovulation rates. Mol Cell Endocrinol. 2012;348:339–43.PubMedCrossRef

26.

Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature. 1996;383:531–5.PubMedCrossRef

27.

Yan C, Wang P, DeMayo J, DeMayo FJ, Elvin JA, Carino C, et al. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol. 2001;15:854–66.PubMedCrossRef

28.

Galloway SM, McNatty KP, Cambridge LM, Laitinen MP, Juengel JL, Jokiranta TS, et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet. 2000;25:279–83.PubMedCrossRef

29.

Hanrahan JP, Gregan SM, Mulsant P, Mullen M, Davis GH, Powell R, et al. Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biol Reprod. 2004;70:900–9.PubMedCrossRef

30.

Juengel JL, Hudson NL, Whiting L, McNatty KP. Effects of immunization against bone morphogenetic protein 15 and growth differentiation factor 9 on ovulation rate, fertilization, and pregnancy in ewes. Biol Reprod. 2004;70:557–61.PubMedCrossRef

31.

Wang B, Zhou S, Wang J, Liu J, Ni F, Yan J, et al. Identification of novel missense mutations of GDF9 in Chinese women with polycystic ovary syndrome. Reprod Biomed Online. 2010;21:344–8.PubMedCrossRef

32.

Palmer JS, Zhao ZZ, Hoekstra C, Hayward NK, Webb PM, Whiteman DC, et al. Novel variants in growth differentiation factor 9 in mothers of dizygotic twins. J Clin Endocrinol Metab. 2006;91:4713–6.PubMedCrossRef

33.

Dixit H, Rao LK, Padmalatha V, Kanakavalli M, Deenadayal M, Gupta N, et al. Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause. 2005;12:749–54.PubMedCrossRef

34.

Chand AL, Ponnampalam AP, Harris SE, Winship IM, Shelling AN. Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure. Fertil Steril. 2006;86:1009–12.PubMedCrossRef

35.

Wang TT, Ke ZH, Song Y, Chen LT, Chen XJ, Feng C, et al. Identification of a mutation in GDF9 as a novel cause of diminished ovarian reserve in young women. Hum Reprod. 2013.

36.

McIntosh CJ, Lun S, Lawrence S, Western AH, McNatty KP, Juengel JL. The proregion of mouse BMP15 regulates the cooperative interactions of BMP15 and GDF9. Biol Reprod. 2008;79:889–96.PubMedCrossRef

37.

Al-Musawi SL, Walton KL, Heath D, Simpson CM, Harrison CA. Species differences in the expression and activity of bone morphogenetic protein 15. Endocrinology. 2013;154:888–99.PubMedCrossRef

38.

Mottershead DG, Pulkki MM, Muggalla P, Pasternack A, Tolonen M, Myllymaa S, et al. Characterization of recombinant human growth differentiation factor-9 signaling in ovarian granulosa cells. Mol Cell Endocrinol. 2008;283:58–67.PubMedCrossRef

39.

Simpson CM, Stanton PG, Walton KL, Chan KL, Ritter LJ, Gilchrist RB, et al. Activation of latent human GDF9 by a single residue change (Gly 391 Arg) in the mature domain. Endocrinology. 2012;153:1301–10.PubMedCrossRef

40.

McIntosh CJ, Lawrence S, Smith P, Juengel JL, McNatty KP. Active immunization against the proregions of GDF9 or BMP15 alters ovulation rate and litter size in mice. Reproduction. 2012;143:195–201.PubMedCrossRef

41.

Gilchrist RB, Ritter LJ, Cranfield M, Jeffery LA, Amato F, Scott SJ, et al. Immunoneutralization of growth differentiation factor 9 reveals it partially accounts for mouse oocyte mitogenic activity. Biol Reprod. 2004;71:732–9.PubMedCrossRef

42.

Lin JY, Pitman-Crawford JL, Bibby AH, Hudson NL, McIntosh CJ, Juengel JL, et al. Effects of species differences on oocyte regulation of granulosa cell function. Reproduction. 2012;144:557–67.PubMedCrossRef

43.

McNatty KP, Lawrence S, Groome NP, Meerasahib MF, Hudson NL, Whiting L, et al. Meat and livestock association plenary lecture 2005. Oocyte signalling molecules and their effects on reproduction in ruminants. Reprod Fertil Dev. 2006;18:403–12.PubMedCrossRef

44.

Dunning KR, Lane M, Brown HM, Yeo C, Robker RL, Russell DL. Altered composition of the cumulus-oocyte complex matrix during in vitro maturation of oocytes. Hum Reprod. 2007;22:2842–50.PubMedCrossRef

45.

Romaguera R, Morato R, Jimenez-Macedo AR, Catala M, Roura M, Paramio MT, et al. Oocyte secreted factors improve embryo developmental competence of cocs from small follicles in prepubertal goats. Theriogenology. 2010.

46.

Hussein TS, Sutton-McDowall ML, Gilchrist RB, Thompson JG. Temporal effects of exogenous oocyte-secreted factors on bovine oocyte developmental competence during IVM. Reprod Fertil Dev. 2011;23:576–84.PubMedCrossRef

47.

Hussein TS, Thompson JG, Gilchrist RB. Oocyte-secreted factors enhance oocyte developmental competence. Dev Biol. 2006;296:514–21.PubMedCrossRef

48.

Gomez MN, Kang JT, Koo OJ, Kim SJ, Kwon DK, Park SJ, et al. Effect of oocyte-secreted factors on porcine in vitro maturation, cumulus expansion and developmental competence of parthenotes. Zygote. 2012;20:135–45.PubMedCrossRef

49.

Yeo CX, Gilchrist RB, Thompson JG, Lane M. Exogenous growth differentiation factor 9 in oocyte maturation media enhances subsequent embryo development and fetal viability in mice. Hum Reprod. 2008;23:67–73.PubMedCrossRef

50.

Gautam SK, Verma V, Palta P, Chauhan MS, Manik RS. Effect of type of cryoprotectant on morphology and developmental competence of in vitro-matured buffalo (Bubalus bubalis) oocytes subjected to slow freezing or vitrification. Reprod Fertil Dev. 2008;20:490–6.PubMedCrossRef

51.

Wigglesworth K, Lee KB, O’Brien MJ, Peng J, Matzuk MM, Eppig JJ. Bidirectional communication between oocytes and ovarian follicular somatic cells is required for meiotic arrest of mammalian oocytes. Proc Natl Acad Sci U S A. 2013;110:E3723–9.PubMedCentralPubMedCrossRef

52.

Zhang K, Hansen PJ, Ealy AD. Fibroblast growth factor 10 enhances bovine oocyte maturation and developmental competence in vitro. Reproduction. 2010;140:815–26.PubMedCrossRef

53.

Solloway MJ, Dudley AT, Bikoff EK, Lyons KM, Hogan BL, Robertson EJ. Mice lacking Bmp6 function. Dev Genet. 1998;22:321–39.PubMedCrossRef

54.

Peng J, Li Q, Wigglesworth K, Rangarajan A, Kattamuri C, Peterson RT, et al. Growth differentiation factor 9: bone morphogenetic protein 15 heterodimers are potent regulators of ovarian functions. Proc Natl Acad Sci U S A. 2013;110:E776–85.PubMedCentralPubMedCrossRef

55.

Mottershead DG, Harrison CA, Mueller TD, Stanton PG, Gilchrist RB, McNatty KP. Growth differentiation factor 9: bone morphogenetic protein 15 (GDF9:BMP15) synergism and protein heterodimerization. Proc Natl Acad Sci U S A. 2013;110:E2257.PubMedCentralPubMedCrossRef

56.

Hickey TE, Marrocco DL, Amato F, Ritter LJ, Norman RJ, Gilchrist RB, et al. Androgens augment the mitogenic effects of oocyte-secreted factors and growth differentiation factor 9 on porcine granulosa cells. Biol Reprod. 2005;73:825–32.PubMedCrossRef

57.

Yoshino O, McMahon HE, Sharma S, Shimasaki S. A unique preovulatory expression pattern plays a key role in the physiological functions of BMP-15 in the mouse. Proc Natl Acad Sci U S A. 2006;103:10678–83.PubMedCentralPubMedCrossRef

Title: Effects of differing oocyte-secreted factors during mouse in vitro maturation on subsequent embryo and fetal development
Authors: J. Sudiman
L. J. Ritter
D. K. Feil
X. Wang
K. Chan
D. G. Mottershead
D. M. Robertson
J. G. Thompson
R. B. Gilchrist
Publication date: 01-03-2014
Publisher: Springer US
Published in: Journal of Assisted Reproduction and Genetics / Issue 3/2014
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-013-0152-5

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Effects of differing oocyte-secreted factors during mouse in vitro maturation on subsequent embryo and fetal development

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2014

Addressing the particular recordkeeping needs of infertile orthodox Jewish couples considering the use of donated eggs

The effects of vaginal lubricants on sperm function: an in vitro analysis

Association between FSHR polymorphisms and polycystic ovary syndrome among Chinese women in north China

Embryo quality but not pronuclear score is associated with clinical pregnancy following IVF

Altered microRNA and gene expression in the follicular fluid of women with polycystic ovary syndrome

Could empirical low-dose-aspirin administration during IVF cycle affect both the oocytes and embryos quality via COX 1–2 activity inhibition?